July 29, 2025
Published by: Zorrox Update Team
Meta Platforms has named Shengjia Zhao, a co-creator of ChatGPT and a lead architect behind GPT-4, as Chief Scientist of its newly established Superintelligence Lab (MSL). CEO Mark Zuckerberg confirmed the appointment in a Threads post, positioning Zhao alongside Chief AI Officer Alexandr Wang to define the lab’s scientific direction.
The Superintelligence Lab was launched in mid-2025 as a dedicated unit for Meta’s most ambitious AI efforts, operating separately from the existing FAIR (Fundamental AI Research) division. While FAIR continues under the leadership of AI veteran Yann LeCun, it now reports to Wang, reflecting Meta’s move to consolidate its AI hierarchy under a unified strategy.
Zhao, who helped launch MSL and has been shaping its research agenda for months, brings direct experience from OpenAI, where he contributed to the development of GPT-4 and other high-efficiency transformer models. His appointment represents a tactical escalation in Meta’s AI race with rivals like OpenAI, Google, and Anthropic.
The announcement follows Meta’s $14.3 billion investment to acquire a 49% stake in Scale AI and the high-profile hiring of Scale founder Alexandr Wang as Chief AI Officer. Zhao’s addition deepens the company’s push to assemble elite AI talent under the MSL umbrella.
The lab is expected to leverage Prometheus, Meta’s 1-gigawatt AI cloud training cluster slated to go live in 2026, giving it the compute backbone to train frontier models at scale. Internally, MSL has been tasked with producing general-purpose systems capable of competing directly with leading models from rival labs.
Despite the momentum, not all internal voices are aligned. LeCun, a pioneer in deep learning, has downplayed talk of superintelligence and criticized the current hype cycle, creating philosophical tensions between FAIR’s foundational research and MSL’s aggressive scaling mandate.
Meta shares (NASDAQ: META) have been trading near all-time highs, but investor sentiment remains closely tied to the company’s execution on AI. Delays in rolling out its large Behemoth model and questions around lab coordination have tempered early enthusiasm around MSL’s formation.
Analysts warn that the dual-lab structure—with FAIR focusing on long-term research and MSL aiming for short-term breakthroughs—could lead to strategic friction or duplication. The challenge for Zuckerberg and Wang is to turn Meta’s AI vision into tangible product and platform enhancements without diluting focus.
Still, the appointment of Zhao gives Meta a credible scientific anchor in a space where reputational signaling matters as much as progress. Whether MSL delivers on its promise will depend on its ability to integrate talent, coordinate across teams, and produce meaningful research outputs over the next 12 to 18 months.
Track Meta (NASDAQ: META) for stock movements tied to MSL milestones, hiring updates, or research releases.
Watch AI infrastructure suppliers such as Nvidia and AMD for potential tailwinds from Meta’s compute expansion.
Monitor statements from FAIR and MSL leaders—any divergence could hint at internal tension or reshuffling.
Be cautious of overbought sentiment: Meta’s rapid AI expansion adds cost pressure and execution complexity.
Evaluate AI ecosystem plays in light of Meta’s positioning—MSL success could shift capital flows across the sector.
© 2024 Zorrox Project. All rights reserved.
Risk Warning:
Trading online involves significant risks and may not be suitable for all investors. The content on this website does not constitute investment advice. Before deciding to trade on our platform, you should thoroughly evaluate your objectives, financial situation, needs, and level of experience, and consider seeking independent professional advice. Trading may result in the loss of some or all of your invested capital; therefore, you should not speculate with funds you cannot afford to lose. Be aware of the risks associated with trading on margin. Please read our full Risk Disclosure Statement and Terms and Conditions.
We do not guarantee profits from trading or any other activities associated with our website. Trading does not grant you access, rights, or ownership to the underlying assets but exposes you to price fluctuations of those assets. If you do not understand or cannot afford the risks involved, you are advised not to trade with us. We do not provide trading advice, recommendations, or guidance. Any trading decision is your sole responsibility and at your own risk, and the Group is not liable for any losses you may incur. Please consult your own legal, financial, and tax advisors for advice and assistance.
Leverage Products:
Leveraged trading products are complex instruments that come with a high risk of losing money rapidly due to leverage. Most retail clients lose money when trading financial instruments. Please consider whether you understand how our products work and whether you can afford the risk of losing your money.
Regulatory Information:
ZORROX operated by Bruce Investments Ltd, 3 Emerald Park, Trianon, Quatre Bornes 72257, Mauritius. Registration Number: C196325, Authorized and regulated by the Financial Services Commission (“FSC”) of Mauritius with License Number GB23201698 as an authorized Investment Dealer. Services are provided only where authorized.
EN-US